| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.0 |
| Other income | 0.1 | 0.1 | 0.7 |
| Total income | 0.1 | 0.1 | 0.7 |
| Profit before exceptional items & tax | 0.0 | 0.0 | 0.4 |
| Profit before tax | 0.0 | 0.0 | 0.4 |
| Net profit | 0.6 | 0.0 | 0.4 |
| Operating margin | 0.0% | 0.0% | 57.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +50.00% |
|---|
Source
Read the filing ↗
BSE results filing, NSE: BACPHAR. Figures extracted from the filing.
Bacil Pharma Ltd: key numbers
- Share price
- ₹26.27
- Market cap
- ₹37.71 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.56 Cr
- P/E (TTM)
- 57.5×Sector 50.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bacil Pharma Ltd
All →
16:14 IST
BSE
Financial Results
Bacil Pharma Q1 FY27 Results: Net Profit ₹0.3 Cr, Down 57.1% YoY
Bacil Pharma Ltd reported net profit of ₹0.3 Cr (-57.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.3 Cr · -57.1% YoY